FOXP1 works as a negative regulator of tumor-specific CD4+ T helper 7 (Th7) cells for cancer immunotherapy, since mature naïve CD4+ T cells proliferate to exert antitumor effect programmed by IL-7 only in the absence of FOXP1 [117, 118]. The gene discussed is CD4; the disease is cancer.